|
US3471513A
(en)
|
1966-11-01 |
1969-10-07 |
Searle & Co |
2-(2-carboxyethyl)-5-phenyl-1-pyrrole-butyric acid and congeners
|
|
BE789077A
(fr)
|
1971-09-22 |
1973-01-15 |
Nitto Boseki Co Ltd |
Procede de preparation de derives de pyrimidine
|
|
JPS5327252B2
(enExample)
|
1973-04-17 |
1978-08-07 |
|
|
|
US4026895A
(en)
|
1973-09-08 |
1977-05-31 |
Eisai Co., Ltd. |
1,3-Benzodioxol derivatives
|
|
US4008323A
(en)
|
1974-03-25 |
1977-02-15 |
Pierre Fabre S.A. |
Method of reducing cholesterol using certain aromatic keto acids
|
|
FR2300551A2
(fr)
|
1975-02-17 |
1976-09-10 |
Fabre Sa Pierre |
Nouveaux
|
|
GB1484413A
(en)
|
1974-04-18 |
1977-09-01 |
Kissei Pharmaceutical |
Aromatic amidocarboxylic acid derivatives
|
|
DE2456958A1
(de)
|
1974-12-03 |
1976-06-16 |
Basf Ag |
3-(p-biphenylyl)-butyronitril und seine anwendung als arzneimittel
|
|
US4031243A
(en)
|
1975-07-03 |
1977-06-21 |
Juste, S.A. Quimico-Farmaceutica |
2-(4-Isobutyl phenyl)butyric acid, salts thereof, and pharmaceutical compositions containing the same
|
|
GB1518764A
(en)
|
1976-03-17 |
1978-07-26 |
Soc D Etudes Prod Chimique |
Isobutyramides their preparation and therapeutic composititions containing them
|
|
US4176193A
(en)
|
1977-03-17 |
1979-11-27 |
Societe D'etudes De Produits Chimiques |
Therapeutic isobutyramides
|
|
US4732914A
(en)
|
1978-02-13 |
1988-03-22 |
The Upjohn Company |
Prostacyclin analogs
|
|
US4234599A
(en)
|
1978-10-04 |
1980-11-18 |
Scott Eugene J Van |
Treatment of skin keratoses with α-hydroxy acids and related compounds
|
|
FR2508797B1
(fr)
|
1981-07-03 |
1986-03-14 |
Charles Chany |
Medicament comprenant le produit de la reaction d'un acide carboxylique en c1 a c6 sur un amino-acide basique
|
|
US4704402A
(en)
|
1982-06-12 |
1987-11-03 |
University Of Pittsburgh |
Method of treating sickle cell anemia
|
|
GB2126082A
(en)
|
1982-08-12 |
1984-03-21 |
Heinrich Schulze |
Pharmaceutical preparations having analgetic and cytostatic activity
|
|
US4894364A
(en)
|
1983-10-26 |
1990-01-16 |
Greer Sheldon B |
Method and materials for sensitizing neoplastic tissue to radiation
|
|
US4851229A
(en)
|
1983-12-01 |
1989-07-25 |
Alza Corporation |
Composition comprising a therapeutic agent and a modulating agent
|
|
US4671901A
(en)
|
1984-01-26 |
1987-06-09 |
Oral-D |
Orally effective ion chelators
|
|
CA1249968A
(en)
|
1984-04-05 |
1989-02-14 |
Kazuo Kigasawa |
Ointment base
|
|
US4747825A
(en)
|
1984-06-29 |
1988-05-31 |
Ferring Laboratories, Inc. |
Apparatus and methodology for pulsed administration of growth promoting agents
|
|
US4613616A
(en)
|
1984-07-20 |
1986-09-23 |
Research Corporation |
Polymeric iron chelators
|
|
JPS61155358A
(ja)
|
1984-12-21 |
1986-07-15 |
Suntory Ltd |
ジアリール酪酸誘導体
|
|
JPS61180740A
(ja)
|
1985-02-05 |
1986-08-13 |
Asahi Chem Ind Co Ltd |
新規なフエニル酢酸又はフエニルチオ酢酸誘導体とそれを有効成分とする植物生育調節剤
|
|
US4735967A
(en)
|
1985-05-28 |
1988-04-05 |
Neesby Torben E |
Method for desensitizing the gastrointestinal tract from food allergies
|
|
DE3534743A1
(de)
|
1985-09-28 |
1987-04-02 |
Beiersdorf Ag |
Hydrocortisondiester enthaltende o/w-creme
|
|
GB8607683D0
(en)
|
1986-03-27 |
1986-04-30 |
Ici Plc |
Anti-tumor agents
|
|
US4751244A
(en)
|
1986-04-04 |
1988-06-14 |
Merck & Co., Inc. |
Compounds useful in treating sickle cell anemia
|
|
US4699926A
(en)
|
1986-04-04 |
1987-10-13 |
Merck & Co., Inc. |
Compounds useful in treating sickle cell anemia
|
|
US4731381A
(en)
|
1986-04-04 |
1988-03-15 |
Merck & Co., Inc. |
Method of treating a person for sickle cell anemia
|
|
US4948592A
(en)
|
1986-05-09 |
1990-08-14 |
Alza Corporation |
Pulsed drug delivery
|
|
US4723958A
(en)
|
1986-05-23 |
1988-02-09 |
Merck & Co., Inc. |
Pulsatile drug delivery system
|
|
US4822821A
(en)
|
1986-10-10 |
1989-04-18 |
Children's Hospital Medical Center Of Northern California |
Method for augmenting fetal hemoglobin
|
|
US5025029A
(en)
|
1986-10-10 |
1991-06-18 |
Children's Hospital Medical Center Of Northern California |
Method for augmenting fetal hemoglobin
|
|
US4965251A
(en)
|
1987-04-03 |
1990-10-23 |
The Board Of Regents Of The University Of Washington |
Pulse treatment of hemoglobinopathies with erythropoietin
|
|
US4849426A
(en)
|
1987-05-15 |
1989-07-18 |
Pearlman Dale L |
Method for treating actinic keratosis with cytotoxic agents
|
|
US4820711A
(en)
|
1987-05-15 |
1989-04-11 |
Pearlman Dale L |
Method for treating actinic keratosis with cytotoxic agents
|
|
US4853388A
(en)
|
1987-05-15 |
1989-08-01 |
Pearlman Dale L |
Method for treating psoriasis with cytotoxic agents
|
|
FR2633929B2
(fr)
|
1987-09-25 |
1995-05-24 |
Picardie Universite |
Derives non toxiques de l'acide n-butyrique, presentant des actions therapeutiques retardees
|
|
US5032507A
(en)
|
1987-11-13 |
1991-07-16 |
The Salk Institute For Biological Studies |
Potentiation of erythropoiesis
|
|
DE3742222A1
(de)
|
1987-12-12 |
1989-06-22 |
Basf Ag |
(2r)-aryloxy-3-n-butyroyloxy-propan-2-ole
|
|
US4880624A
(en)
|
1988-03-18 |
1989-11-14 |
The Board Of Trustees Of The University Of Illinois |
Volatile attractants for diabrotica species
|
|
GB8912700D0
(en)
|
1989-06-02 |
1989-07-19 |
Shell Int Research |
Herbicidal compounds
|
|
DE68914197T2
(de)
|
1988-06-20 |
1994-11-10 |
Ihara Chemical Ind Co |
Alkansäurederivate und herbizide Mittel.
|
|
US4958592A
(en)
|
1988-08-22 |
1990-09-25 |
General Electric Company |
Resistance heater for diamond production by CVD
|
|
US4925873A
(en)
|
1988-09-01 |
1990-05-15 |
E. R. Squibb & Sons, Inc. |
Method of treating skin injuries using thromboxane A2 receptor antagonists
|
|
US4997815A
(en)
|
1988-11-01 |
1991-03-05 |
Children's Hospital Medical Center Of Northern California |
Method for augmenting fetal hemoglobin by treatment with activin and/or inhibin
|
|
US5137734A
(en)
|
1989-03-22 |
1992-08-11 |
Dana Farber Cancer Institute |
Angiogenic monoglycerides
|
|
US5039703A
(en)
|
1989-11-16 |
1991-08-13 |
Breuer Richard I |
Method for treating inflammatory bowel disorders
|
|
GB8929070D0
(en)
|
1989-12-22 |
1990-02-28 |
Fujisawa Pharmaceutical Co |
Peptide compounds,processes for preparation thereof and pharmaceutical composition comprising the same
|
|
US5674898A
(en)
|
1990-03-05 |
1997-10-07 |
Genzyme Corporation |
Methods and therapeutic compositions for treating cystic fibrosis
|
|
US5258367A
(en)
|
1990-06-29 |
1993-11-02 |
University Of Florida |
Uteroferrin and rose proteins for stimulating hematopoietic cells
|
|
US5216004A
(en)
|
1990-09-13 |
1993-06-01 |
Children's Hospital Medical Center Of North California |
Method for preventing malaria
|
|
US5100647A
(en)
|
1990-10-02 |
1992-03-31 |
The Trustees Of The University Of Pennsylvania |
Method and formulations for the therapy of cystic fibrosis, Bartter's syndrome and secretory diarrheas, and for diuretic treatment
|
|
US5674912A
(en)
|
1991-03-01 |
1997-10-07 |
Warner-Lambert Company |
Sunscreen-wound healing compositions and methods for preparing and using same
|
|
US5851828A
(en)
|
1991-03-07 |
1998-12-22 |
The General Hospital Corporation |
Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
|
|
US5270458A
(en)
|
1991-04-02 |
1993-12-14 |
The Trustees Of Princeton University |
Nucleic acids encoding fragments of hematopoietic stem cell receptor flk-2
|
|
US5199942A
(en)
|
1991-06-07 |
1993-04-06 |
Immunex Corporation |
Method for improving autologous transplantation
|
|
US5605930A
(en)
|
1991-10-21 |
1997-02-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
Compositions and methods for treating and preventing pathologies including cancer
|
|
US5635532A
(en)
|
1991-10-21 |
1997-06-03 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Compositions and methods for therapy and prevention of pathologies including cancer, AIDS and anemia
|
|
AU2804592A
(en)
|
1991-10-21 |
1993-05-21 |
Dvorit Samid |
Compositions and methods for therapy and prevention of cancer, aids, and anemia
|
|
ATE188119T1
(de)
|
1992-02-07 |
2000-01-15 |
Kaken Pharma Co Ltd |
Heilmittel für wunden und hämorrhoiden
|
|
CA2090283A1
(en)
|
1992-02-28 |
1993-08-29 |
Nobuyuki Hamanaka |
Phenoxyacetic acid derivatives
|
|
US5366996A
(en)
|
1992-12-07 |
1994-11-22 |
Elford Howard L |
Method of treating hemoglobinopathies
|
|
US5403590A
(en)
|
1992-12-21 |
1995-04-04 |
New England Deaconess Hospital Corporation |
Method of pulsatile drug infusion
|
|
AU696167B2
(en)
|
1993-10-29 |
1998-09-03 |
Trustees Of Boston University |
Physiologically stable compositions of butyric acid, and butyric acid salts and derivatives as anti-neoplastic agents
|
|
US5827642A
(en)
|
1994-08-31 |
1998-10-27 |
Fred Hutchinson Cancer Research Center |
Rapid expansion method ("REM") for in vitro propagation of T lymphocytes
|
|
US6011000A
(en)
|
1995-03-03 |
2000-01-04 |
Perrine; Susan P. |
Compositions for the treatment of blood disorders
|
|
WO1997004761A1
(en)
|
1995-07-28 |
1997-02-13 |
Trustees Of Boston University |
Methods and compositions for treating cell proliferative disorders
|
|
US5763488A
(en)
|
1995-10-30 |
1998-06-09 |
Vertex Pharmaceuticals Incorporated |
Methods and compositions using butyrate esters of threitol
|
|
ATE476496T1
(de)
|
1996-03-04 |
2010-08-15 |
Calyx Bio Ventures Inc |
Modifizierte schnellvermehrungsmethode ('modified-rem') zur in vitro vermehrung von t-lymphozyten
|
|
DE69713336T2
(de)
|
1996-03-30 |
2002-12-05 |
Science Park Raf S.P.A., Milano |
Verfahren zur Herstellung von aktivierten markierten tumorspezifischen T-Zellen und deren Verwendung in der Behandlung von Tumoren
|
|
US6197743B1
(en)
|
1996-07-26 |
2001-03-06 |
The Trustees Of Boston University |
Compositions and methods for the treatment of viral disorders
|
|
EP1886677A1
(en)
|
1996-07-26 |
2008-02-13 |
Susan P. Perrine |
Use of an inducing agent for the treatment of blood, viral and cellular disorders
|
|
US6403647B1
(en)
|
1996-07-26 |
2002-06-11 |
Susan P. Perrine |
Pulsed administration of compositions for the treatment of blood disorders
|
|
US5939456A
(en)
|
1996-07-26 |
1999-08-17 |
Perrine; Susan P. |
Pulsed administration of compositions for the treatment of blood disorders
|
|
US6030961A
(en)
|
1997-03-11 |
2000-02-29 |
Bar-Ilan Research & Development Co., Ltd. |
Oxyalkylene phosphate compounds and uses thereof
|
|
US6043389A
(en)
|
1997-03-11 |
2000-03-28 |
Mor Research Applications, Ltd. |
Hydroxy and ether-containing oxyalkylene esters and uses thereof
|
|
US5932545A
(en)
|
1997-03-17 |
1999-08-03 |
Abbott Laboratories |
Antiangiogenic drug to treat cancer, arthritis and retinopathy
|
|
US6231880B1
(en)
|
1997-05-30 |
2001-05-15 |
Susan P. Perrine |
Compositions and administration of compositions for the treatment of blood disorders
|
|
WO1999040883A2
(en)
|
1998-02-11 |
1999-08-19 |
Faller Douglas V |
Compositions and methods for the treatment of cystic fibrosis
|
|
US7541184B2
(en)
|
2000-02-24 |
2009-06-02 |
Invitrogen Corporation |
Activation and expansion of cells
|
|
US20030134341A1
(en)
|
2001-09-19 |
2003-07-17 |
Medcell Biologics, Llc. |
Th1 cell adoptive immunotherapy
|
|
US7745140B2
(en)
|
2002-01-03 |
2010-06-29 |
The Trustees Of The University Of Pennsylvania |
Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool
|
|
US8946295B2
(en)
|
2002-07-25 |
2015-02-03 |
Sunny Pharmtech Inc. |
Histone hyperacetylating agents for promoting wound healing and preventing scar formation
|
|
DK2112162T3
(da)
|
2004-07-10 |
2015-02-23 |
Fox Chase Cancer Ct |
Genetisk modificerede humane naturlige dræbercellelinjer
|
|
US20080015190A1
(en)
|
2004-07-12 |
2008-01-17 |
Chakravarty Prasun K |
Inhibitors of Histone Deacetylase
|
|
US20060069060A1
(en)
|
2004-09-27 |
2006-03-30 |
Sanjeev Redkar |
Salts of decitabine
|
|
US7135833B2
(en)
*
|
2004-11-30 |
2006-11-14 |
Rockwell Automation Technologies, Inc. |
Motor control for flux-reduced braking
|
|
FR2881746B1
(fr)
|
2005-02-07 |
2007-04-13 |
Centre Nat Rech Scient |
Epitopes t cd4+des antigenes de latence de type i et ii du virus epstein-barr aptes a etre reconnus par la majorite des individus de la population caucasienne et leurs applications
|
|
GB0509225D0
(en)
|
2005-05-05 |
2005-06-15 |
Chroma Therapeutics Ltd |
Inhibitors of enzymatic activity
|
|
EP2439273B1
(en)
|
2005-05-09 |
2019-02-27 |
Ono Pharmaceutical Co., Ltd. |
Human monoclonal antibodies to programmed death 1(PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics
|
|
GB0510204D0
(en)
*
|
2005-05-19 |
2005-06-22 |
Chroma Therapeutics Ltd |
Enzyme inhibitors
|
|
AU2007249827A1
(en)
|
2006-05-09 |
2007-11-22 |
Colorado State University Research Foundation |
Methods for treating blood disorders
|
|
US20080057086A1
(en)
|
2006-09-01 |
2008-03-06 |
Pharmion Corporation |
Colon-targeted oral formulations of cytidine analogs
|
|
GB0619753D0
(en)
|
2006-10-06 |
2006-11-15 |
Chroma Therapeutics Ltd |
Enzyme inhibitors
|
|
PL2343286T3
(pl)
|
2006-10-28 |
2015-06-30 |
Methylgene Inc |
Pochodne dibenzo[b,f][1,4]oksazepiny jako inhibitory deacetylazy histonowej
|
|
CA2668070A1
(en)
|
2006-10-30 |
2008-05-08 |
Chroma Therapeutics Ltd. |
Hydroxamates as inhibitors of histone deacetylase
|
|
EP2124918A4
(en)
|
2007-02-08 |
2011-09-14 |
Merck Sharp & Dohme |
METHOD OF USE OF SAHA FOR THE TREATMENT OF HIV INFECTIONS
|
|
WO2009067453A1
(en)
|
2007-11-19 |
2009-05-28 |
Syndax Pharmaceuticals, Inc. |
Combinations of hdac inhibitors and proteasome inhibitors
|
|
US8383099B2
(en)
|
2009-08-28 |
2013-02-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Adoptive cell therapy with young T cells
|
|
WO2011038224A1
(en)
|
2009-09-24 |
2011-03-31 |
Trustees Of Boston University |
Methods for treating viral disorders
|
|
US8491927B2
(en)
|
2009-12-02 |
2013-07-23 |
Nimble Epitech, Llc |
Pharmaceutical composition containing a hypomethylating agent and a histone deacetylase inhibitor
|
|
MA33899B1
(fr)
|
2009-12-08 |
2013-01-02 |
Hemaquest Pharmaceuticals Inc |
Procedes et regimes a faible dose pour des troubles des globules rouges
|
|
US20110245154A1
(en)
|
2010-03-11 |
2011-10-06 |
Hemaquest Pharmaceuticals, Inc. |
Methods and Compositions for Treating Viral or Virally-Induced Conditions
|
|
PH12013501201A1
(en)
|
2010-12-09 |
2013-07-29 |
Univ Pennsylvania |
Use of chimeric antigen receptor-modified t cells to treat cancer
|
|
CA3179835A1
(en)
|
2011-01-18 |
2012-07-26 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treating cancer
|
|
CA2866333C
(en)
|
2011-03-09 |
2020-12-29 |
Cereno Scientific Ab |
Compounds and methods for improving impaired endogenous fibrinolysis using histone deacetylase inhibitors
|
|
UA123212U
(uk)
|
2011-09-02 |
2018-02-26 |
Общєство С Огранічєной Отвєтствєностью "Новамедіка" |
Спосіб лікування раку молочної залози
|
|
CN103917231B
(zh)
|
2011-09-13 |
2016-09-28 |
药品循环有限责任公司 |
组蛋白脱乙酰酶抑制剂与苯达莫司汀的联合制剂及其用途
|
|
US9708384B2
(en)
|
2011-09-22 |
2017-07-18 |
The Trustees Of The University Of Pennsylvania |
Universal immune receptor expressed by T cells for the targeting of diverse and multiple antigens
|
|
WO2013050422A1
(en)
|
2011-10-03 |
2013-04-11 |
Université Libre de Bruxelles |
Reactivation of hiv-1 gene expression to treat persistent hiv infection
|
|
CN102391359B
(zh)
|
2011-11-17 |
2014-07-16 |
南京优科生物医药研究有限公司 |
组蛋白去乙酰化酶抑制剂及其合成方法和制药用途
|
|
WO2013086379A2
(en)
*
|
2011-12-08 |
2013-06-13 |
Fundacion Sales |
Methods and compositions for treating antiprogestin-resistant cancers
|
|
EP2806870A1
(en)
|
2012-01-27 |
2014-12-03 |
Aarhus Universitet |
Panobinostat for use in the treatment of hiv-1
|
|
US20150099012A1
(en)
|
2012-03-02 |
2015-04-09 |
Erasmus University Medical Center Rotterdam |
Methods for activating retrovirus in latent infected cells, and compounds for use therein
|
|
WO2013149026A2
(en)
|
2012-03-30 |
2013-10-03 |
The Johns Hopkins University |
Use of n-(4-((3-(2-amino-4-pyrimidinyl) -2-pyridinyl)oxy)phenyl)-4-(4-methyl -2-thienyl)-1-phthalazinamine in combination with histone deacetylase inhibitors for treatment of cancer
|
|
WO2013181584A2
(en)
|
2012-06-01 |
2013-12-05 |
Guo, Ju-Tao |
Modulation of hepatitis b virus cccdna transcription
|
|
CN102793693A
(zh)
|
2012-09-07 |
2012-11-28 |
天津医科大学 |
伏立诺他在制备治疗自身免疫及炎症性疾病药物方面的应用
|
|
US9415070B2
(en)
|
2012-11-09 |
2016-08-16 |
Massachusetts Institute Of Technology |
Methods and compositions for localized delivery of agents to virally infected cells and tissues
|
|
US10745483B2
(en)
|
2013-03-15 |
2020-08-18 |
Dana-Farber Cancer Institute, Inc. |
Therapeutic peptides
|
|
CN103232474A
(zh)
|
2013-04-16 |
2013-08-07 |
中国药科大学 |
组蛋白去乙酰化酶抑制剂
|
|
WO2015010096A1
(en)
|
2013-07-18 |
2015-01-22 |
Baylor College Of Medicine |
Method of enhancing potency of immune cells
|
|
CA2933881A1
(en)
|
2013-12-17 |
2015-06-25 |
Genentech, Inc. |
Methods of treating cancer using pd-1 axis binding antagonists and an anti-cd20 antibody
|
|
KR102313381B1
(ko)
|
2013-12-19 |
2021-10-14 |
퓨어테인 바이오사이언스, 엘엘씨. |
동물을 치료하기 위한 방법
|
|
JOP20200096A1
(ar)
*
|
2014-01-31 |
2017-06-16 |
Children’S Medical Center Corp |
جزيئات جسم مضاد لـ tim-3 واستخداماتها
|
|
WO2015160986A2
(en)
|
2014-04-16 |
2015-10-22 |
Infinity Pharmaceuticals, Inc. |
Combination therapies
|
|
CN104083763A
(zh)
|
2014-07-16 |
2014-10-08 |
中国人民解放军军事医学科学院野战输血研究所 |
组蛋白去乙酰化酶抑制剂在制备潜伏病毒激活剂中的应用
|
|
RU2555474C1
(ru)
|
2014-09-09 |
2015-07-10 |
Государственное бюджетное образовательное учреждение высшего профессионального образования "Ростовский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ГБОУ ВПО РостГМУ Минздрава России) |
Способ лечения эпштейна-барр вирусной инфекции у детей с вич-инфекцией
|
|
US10813952B2
(en)
|
2014-11-14 |
2020-10-27 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
NK cells with an increased antibody-dependent cellular toxicity (ADCC) against tumors
|
|
TWI595006B
(zh)
*
|
2014-12-09 |
2017-08-11 |
禮納特神經系統科學公司 |
抗ｐｄ－１抗體類和使用彼等之方法
|
|
HK1245140A1
(zh)
*
|
2014-12-31 |
2018-08-24 |
Celgene Corporation |
使用自然杀伤细胞治疗血液病症、实体瘤或感染性疾病的方法
|
|
US20180044418A1
(en)
|
2015-03-20 |
2018-02-15 |
Merck Sharp & Dohme Corp. |
Combination of a pd-1 antagonist and vorinostat for treating cancer
|
|
US20170021002A1
(en)
*
|
2015-05-18 |
2017-01-26 |
Batu Biologics, Inc. |
Augmentation of cancer and cancer endothelial vaccine immunogenicity by histone deacetylase inhibitors
|
|
EP3307282A4
(en)
*
|
2015-06-12 |
2019-05-01 |
Immunomedics, Inc. |
DISEASE THERAPY WITH CONSTRUCTS OF CHIMERIC ANTIGEN RECEPTOR (CAR) AND T-CELL (CAR-T) OR NK-CELL (CAR-NK) EXPRESSIVE CAR CONSTRUCTS
|
|
WO2016205695A1
(en)
|
2015-06-19 |
2016-12-22 |
Faller Douglas V |
Methods and compositions for treating herpesvirus induced conditions
|
|
DK3322731T3
(da)
*
|
2015-07-14 |
2021-03-08 |
Bristol Myers Squibb Co |
Fremgangsmåde til behandling af cancer ved hjælp af immun checkpoint-hæmmer; antistof der binder til programmed death-1-receptor (pd-1) eller programmed death ligand-1 (pd-l1)
|
|
CN105055386A
(zh)
|
2015-08-12 |
2015-11-18 |
天津医科大学总医院 |
伏立诺他用于制备免疫调节药物的应用
|
|
EP3345002A4
(en)
|
2015-09-02 |
2019-05-08 |
Syndax Pharmaceuticals Inc. |
SELECTION OF PATIENTS FOR COMBINATION THERAPY
|
|
WO2017053823A1
(en)
|
2015-09-25 |
2017-03-30 |
Pharmacyclics Llc |
Treatment using hdac inhibitors and immunotherapy
|
|
ITUB20155193A1
(it)
|
2015-11-03 |
2017-05-03 |
Italfarmaco Spa |
Sospensioni orali di Givinostat fisicamente e chimicamente stabili
|
|
CA3007996A1
(en)
*
|
2015-12-09 |
2017-06-15 |
Nant Holdings Ip, Llc |
Compositions and methods for treatment of her2 positive metastatic breast cancer
|
|
US20190183870A1
(en)
*
|
2016-01-05 |
2019-06-20 |
The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services |
Combination of histone deacetylase inhibitor and immunotherapy
|
|
CN110699371A
(zh)
*
|
2016-03-18 |
2020-01-17 |
江苏普瑞康生物医药科技有限公司 |
一种基于FcγRⅢa的嵌合基因及其用途
|
|
TWI808055B
(zh)
*
|
2016-05-11 |
2023-07-11 |
美商滬亞生物國際有限公司 |
Hdac 抑制劑與 pd-1 抑制劑之組合治療
|
|
TWI794171B
(zh)
|
2016-05-11 |
2023-03-01 |
美商滬亞生物國際有限公司 |
Ｈｄａｃ抑制劑與ｐｄ-ｌ１抑制劑之組合治療
|
|
PL3458053T3
(pl)
|
2016-05-20 |
2022-04-25 |
Biohaven Therapeutics Ltd. |
Stosowanie riluzolu, proleków riluzolu lub analogów riluzolu z immunoterapiami w leczeniu nowotworów
|
|
KR102677451B1
(ko)
|
2016-05-25 |
2024-06-24 |
인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) |
암 치료 방법 및 조성물
|
|
EP3478312A4
(en)
*
|
2016-06-30 |
2020-07-29 |
Nant Holdings IP, LLC |
NANT CANCER VACCINE
|
|
EP4650005A2
(en)
|
2016-07-15 |
2025-11-19 |
Viracta Subsidiary, Inc. |
Histone deacetylase inhibitors for use in immunotherapy
|
|
AU2017350957B2
(en)
*
|
2016-10-28 |
2020-10-29 |
Nant Holdings Ip, Llc |
Avatar dendritic cells: the neoantigen natural killer T-cell chemo immuno radiation composition inducing immunogenic cell death
|
|
US10799536B2
(en)
*
|
2016-12-09 |
2020-10-13 |
Onk Therapeutics Limited |
Method of treating multiple myeloma using natural killer cells expressing a chimeric antigen receptor for CD38
|
|
JP2021520184A
(ja)
*
|
2017-09-29 |
2021-08-19 |
ナントセル，インコーポレイテッド |
Ｃｄ１ｄ及びｔｃｒ−ｎｋｔ細胞
|
|
TW201922282A
(zh)
|
2017-10-13 |
2019-06-16 |
大陸商江蘇恆瑞醫藥股份有限公司 |
Ｐｄ-１抗體和表觀遺傳調節劑聯合在製備治療腫瘤的藥物中的用途
|
|
WO2019135957A1
(en)
*
|
2018-01-04 |
2019-07-11 |
Nantomics, Llc |
Immune gene expression signature in treg enriched tumor samples
|
|
EP3737405A4
(en)
|
2018-01-12 |
2021-10-06 |
Viracta Therapeutics, Inc. |
EPIGENETIC MODIFIERS FOR USE IN CELLULAR IMMUNOTHERAPY
|
|
CN112533613A
(zh)
|
2018-02-06 |
2021-03-19 |
通用医疗公司 |
作为肿瘤免疫应答的生物标志物的重复rna
|
|
WO2019195420A1
(en)
*
|
2018-04-04 |
2019-10-10 |
Nant Holding IP, LLC |
Advanced avartar dendritic cells
|
|
US11823773B2
(en)
*
|
2018-04-13 |
2023-11-21 |
Nant Holdings Ip, Llc |
Nant cancer vaccine strategies
|
|
WO2023003972A1
(en)
|
2021-07-21 |
2023-01-26 |
Viracta Subsidiary, Inc. |
Cancer treatment combinations
|